US 10071168
Polyoxazoline antibody drug conjugates
granted A61KA61K47/557A61K47/59
Quick answer
US patent 10071168 (Polyoxazoline antibody drug conjugates) held by Serina Therapeutics, Inc. expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Serina Therapeutics, Inc.
- Grant date
- Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K47/557, A61K47/59, A61K47/60, A61K47/68031